Comoros Technology Digest
SEE OTHER BRANDS

Get your science and technology news from Comoros

Comoros Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Comoros Technology Digest.

Press releases published on June 3, 2025

TruGolf to Paricipate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Conference Presented by Maxim Group LLC on Wednesday, June 4th at 3:00 PM EDT

TruGolf to Paricipate in the “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow” Conference Presented by Maxim Group LLC on Wednesday, June 4th at 3:00 PM EDT

Salt Lake City, Utah, June 03, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company, announced today that Brenner Adams, TruGolf’s Chief Growth Officer will present at the “2025 Virtual Tech Conference: Discover …

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer

Teva Announces Pricing and Early Acceptance Results of its Debt Tender Offer

TEL AVIV, Israel, June 03, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today the pricing and early acceptance results of its previously announced tender offers (the “Offers”) to purchase for cash …

WinnerMining launches new energy power project.

WinnerMining launches new energy power project.

Boston, Massachusetts, June 03, 2025 (GLOBE NEWSWIRE) -- With the changes of the times and the advancement of technology, people's attitudes towards energy have also changed. People also understand how cloud mining works. However, traditional cloud mining …

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 IRSF Rett Syndrome Scientific Meeting Reviewing Recent Updates from the TSHA-102 Clinical Program

Recently disclosed clinical cohort data from high (1x1015 total vg) and low dose (5.7x1014 total vg) TSHA-102 from REVEAL adolescent/adult and pediatric Phase 1/2 trials Caregiver research regarding gain/regain of developmental milestones supporting …

Fennec Announces Results of Annual Meeting

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 25, 2025 were elected as directors of …

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024

DBV Technologies publie un amendement à son Document d’enregistrement universel 2024

Châtillon, France, le 3 juin 2025 DBV Technologies publie un amendement à son Document d’enregistrement universel 2024 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), (la « Société »), société biopharmaceutique en …

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document

Châtillon, France, June 03, 2025 DBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company …

Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa

Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa

ORION OYJ LEHDISTÖTIEDOTE 3.6.2025 klo 23.30          Yhdysvaltain lääkeviranomainen FDA hyväksyi kolmannen käyttöaiheen darolutamidille edennyttä eturauhassyöpää sairastavien potilaiden hoidossa Darolutamidi on ensimmäinen ja ainoa androgeenireseptorin …

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer

ORION CORPORATION PRESS RELEASE 3 JUNE 2025 at 23.30 EEST           U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer Darolutamide is the first and only in the U.S. and FDA-approved androgen receptor inhibitor ( …

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …

HeartCore Signs 15th Go IPO Contract

HeartCore Signs 15th Go IPO Contract

NEW YORK and TOKYO, June 03, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and data consulting services company based in Tokyo, announced that it has signed an agreement (“ …

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

ROCKVILLE, MD, June 03, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today …

IGEL übernimmt Stratodesk: Mehr Reichweite und mehr Kompetenz im sicheren Endpoint Computing

IGEL übernimmt Stratodesk: Mehr Reichweite und mehr Kompetenz im sicheren Endpoint Computing

FORT LAUDERDALE, Florida, June 03, 2025 (GLOBE NEWSWIRE) -- IGEL, die sichere Endpoint-OS-Plattform für SaaS, DaaS, VDI und sichere Enterprise-Browser, gibt heute die Übernahme von Stratodesk bekannt – einem renommierten Anbieter von Betriebssystem- und …

Innventure to Participate in Upcoming Investor Conferences

Innventure to Participate in Upcoming Investor Conferences

ORLANDO, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a technology commercialization platform, today announced its participation at the following investor conferences: June 12, 2025 – Lucas Harper, Chief Investment …

Fortrea to Present at the Jefferies Global Healthcare Conference

Fortrea to Present at the Jefferies Global Healthcare Conference

DURHAM, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced that Chairman and Interim Chief Executive Officer, Peter M. Neupert and Chief Financial Officer, Jill McConnell …

AGM Group Holdings Inc. Announces Completion of 50 for 1 Share Consolidation

AGM Group Holdings Inc. Announces Completion of 50 for 1 Share Consolidation

Beijing, June 03, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales of high-performance hardware and computing equipment, announced …

SPS Commerce to Present at the 1st Annual D.A. Davidson Technology & Consumer Conference

SPS Commerce to Present at the 1st Annual D.A. Davidson Technology & Consumer Conference

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced that management will present at the 1st Annual D.A. Davidson Technology …

Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA

Anaptys Announces Positive Rosnilimab Data Updated Through Six Months in Robust Phase 2b Trial in RA

Best-in-disease profile with JAK-like efficacy and monthly (Q4W) dosing in both three-month placebo-controlled and six-month​ blinded treatment period Favorable safety and tolerability, particularly when compared to standard of care biologics or JAKs Max …

Windtree Announces Plan for Cryptocurrency Treasury Policy

Windtree Announces Plan for Cryptocurrency Treasury Policy

WARRINGTON, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating company and advancing early and late-stage innovative therapies …

Ataccama ONE available on Snowflake Marketplace, integrates Document AI

Ataccama ONE available on Snowflake Marketplace, integrates Document AI

BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Ataccama, the data trust company, today announced at Snowflake’s annual user conference, Snowflake Summit 2025, the availability of its unified data trust platform, Ataccama ONE, on Snowflake Marketplace. The …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service